| 摘要: |
| 近年来欧美各国采用英夫利昔治疗克罗恩病，取得了一定的进展，但目前国内相关报道仍较少。本文从诱导缓解、维持缓解、并发症治疗、常见不良反应及处理等方面介绍了英夫利昔在国外的应用进展。 |
| 关键词: 克罗恩病 英夫利昔 诱导缓解 维持缓解 不良反应 |
| DOI：10.11724/jdmu.2009.04.30 |
| 分类号:R979.5 |
| 基金项目: |
|
| Progression of Infliximab in the treatment of Crohn’s Disease |
|
GENG Xue-si1, ZHANG Zhi-qian2
|
|
1.Xiamen Hospital of Traditional Chinese Medicine Affiliated to Fujian College of Traditional Chinese Medicine, Xiamen 361009, China;2.Fujian College of Traditional Chinese Medicine Fujian, Fuzhou 50108, China
|
| Abstract: |
| Infliximab has been used for Crohn’s disease in European and American countries recently, with some progress in the treatment of the disease. But there is still little literature on this medicine right now in China. This article reviewed the progression of Infliximab in treating Crohn's disease abroad from the aspects of inducing remission, maintaining remission, treatment of complications and common adverse reactions and their management. |
| Key words: crohn's disease Infliximab induce remission maintain remission adverse reaction |
